Maddy L. Newby

Southampton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Author Correction: Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design.

Author Correction: Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design.

Journal: Nature communications
Published: August 13, 2026

mRNA delivery of a class 1/4 SARS-CoV-2 neutralizing antibody protects against diverse sarbecoviruses in a lethal mouse challenge model.

mRNA delivery of a class 1/4 SARS-CoV-2 neutralizing antibody protects against diverse sarbecoviruses in a lethal mouse challenge model.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 08, 2026

Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design.

Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design.

Journal: Science (New York, N.Y.)
Published: May 07, 2026

Differential contributions of human oligosaccharyltransferase complexes OST-A and OST-B to HIV-1 envelope glycoprotein glycosylation.

Differential contributions of human oligosaccharyltransferase complexes OST-A and OST-B to HIV-1 envelope glycoprotein glycosylation.

Journal: Journal of virology
Published: March 04, 2026

Structure-based design of stable recombinant hepatitis C virus E1E2 heterodimers.

Structure-based design of stable recombinant hepatitis C virus E1E2 heterodimers.

Journal: Nature communications
Published: January 12, 2026

Consistent Induction of Broadly Neutralizing HIV Antibodies by a Novel Two-Step Mechanism Informs Immunogen Design.

Consistent Induction of Broadly Neutralizing HIV Antibodies by a Novel Two-Step Mechanism Informs Immunogen Design.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Isoform-dependent glycosylation of respiratory viral class I fusion glycoproteins by oligosaccharyltransferases.

Isoform-dependent glycosylation of respiratory viral class I fusion glycoproteins by oligosaccharyltransferases.

Journal: Virology
Published: October 24, 2025

Differential contributions of human oligosaccharyltransferase complexes OST-A and OST-B to HIV-1 envelope glycoprotein glycosylation.

Differential contributions of human oligosaccharyltransferase complexes OST-A and OST-B to HIV-1 envelope glycoprotein glycosylation.

Journal: bioRxiv : the preprint server for biology
Published: September 15, 2025

Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design.

Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design.

Journal: bioRxiv : the preprint server for biology
Published: June 04, 2025

Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design.

Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design.

Journal: Nature communications
Published: May 22, 2025

The origin, diagnosis, and prognosis of oligomannose-type diffuse large B-cell lymphoma.

The origin, diagnosis, and prognosis of oligomannose-type diffuse large B-cell lymphoma.

Journal: Blood
Published: March 14, 2025

Rational design of next-generation filovirus vaccines through glycoprotein stabilization, nanoparticle display, and glycan modification.

Rational design of next-generation filovirus vaccines through glycoprotein stabilization, nanoparticle display, and glycan modification.

Journal: bioRxiv : the preprint server for biology
Published: March 10, 2025
Showing 1-12 of 34

Last Updated: 09/26/2026